CHIEF-HF

Janssen, researchers discuss evolving digital trial challenges alongside launch of remote, 1,900-person drug study
By Dave Muoio | 02:23 pm | November 18, 2019
Digital and remote clinical trial designs have plenty to offer in terms of cost and efficiency, but data handling and other concerns suggest there's still work to be done, according to experts at the American Heart Association Scientific Sessions 2019 in Philadelphia.